The abstract is read at the publisher; the summary is JClub's.
Glucuronidated metabolites of tetrabromobisphenol A (TBBPA) and its glucoside derivatives preferentially accumulate in the basolateral chamber, indicating enhanced transintestinal barrier transport.
- Why it matters: Intestinal metabolism can reshape which chemical forms cross the barrier, but how glycosylation versus glucuronidation alters transport fate is unclear for human-relevant intestinal cells.
- What they did: Using an in vitro Caco-2 cell model, intestinal absorption, metabolism, and metabolite distribution were measured for TBBPA, TBBPA di-β-D-glucoside (TBBPA DG), and TBBPA mono-β-D-glucoside (TBBPA MG), with glucose moieties reducing uptake and metabolism (p < 0.001).
- The result: Metabolites of TBBPA DG mostly stayed apical (84.6%), TBBPA mainly entered basolateral (76.0%), and TBBPA MG was intermediate (42.6% apical vs. 48.3% basolateral), while glucuronidated metabolites were preferentially basolateral, supported by molecular docking.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.